Evaluation of Multi-strain Lactobacillus Capsule on Gastric Emptying Function by Tc-99m Scintigraphy in a Crossover Placebo-Controlled Clinical Trial

被引:4
|
作者
Wang, Yuh-Feng [2 ,3 ]
Huang, Hsin-Yu [1 ,4 ]
Chiu, Yung-Wei [5 ,6 ,7 ]
Chao, Wei-Hsun [4 ]
Chuang, Tzyy-Ling [2 ]
Lu, Ying-Chen
Lin, Meei-Yn [1 ]
机构
[1] Natl Chung Hsing Univ, Dept Food Sci & Biotechnol, Taichung 40227, Taiwan
[2] Dalin Tzu Chi Gen Hosp, Dept Nucl Med, Chiayi, Taiwan
[3] Tzu Chi Univ, Sch Med, Hualien, Taiwan
[4] Wu Feng Univ, Dept Early Childhood Educare, Chiayi, Taiwan
[5] Chung Shan Med Univ, Inst Med, Taichung, Taiwan
[6] Tungs Taichung MetroHarbor Hosp, Emergency Dept, Taichung, Taiwan
[7] Tungs Taichung MetroHarbor Hosp, Hyperbar Oxygen Therapy Ctr, Taichung, Taiwan
关键词
Lactobacillus; gastric emptying; gastroparesis; scintigraphy clinical trial; HELICOBACTER-PYLORI INFECTION; CHAIN FATTY-ACIDS; GASTROINTESTINAL MOTILITY; GLYCEMIC CONTROL; MURINE MODEL; GUT FLORA; GASTROPARESIS; PROBIOTICS; CISAPRIDE; DYSPEPSIA;
D O I
10.6227/jfda.2012200312
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Current pharmacological therapy for gastroparesis is limited by a few optional agents with high side effect profiles. Probiotics, which exert both prokinetic and antibiotic properties, can be a good alternative. This study investigates the effects of capsules containing three species of Lactobacillus on gastric emptying function by using a crossover placebo-controlled clinical trial. The 15 healthy participants recruited were divided into two groups, with one group of 7 persons aged between 20-40 and another group of 8 persons aged between 41-60. All the participants in each group were provided with placebo capsules and probiotic capsules, respectively, to be taken twice a day after meals for 3 weeks with crossover in the following 3 weeks. Tc-99m scintigraphy was performed at the beginning of weeks 0, 3 and 610 determine the gastric emptying rate. All time-activity curves were constructed and the half time of gastric emptying (GEt1/2) was calculated for the same subject for comparison. The GEt1/2 of the baseline, placebo and Lactobacillus regimen periods for the 20-40 age group were 73.0 +/- 16.0, 85.7 +/- 10.5, and 87.8 +/- 10.0 min, respectively, while those for the 41-60 age group were 79.1 +/- 23.9, 70.9 +/- 33.1, and 68.4 +/- 15.2 min, respectively. Comparison of the two groups showed a positive effect of probiotics capsules on the 41 to 60-year-old participants (p=0.013) but not on the 20 to 40-year-old participants. There was no significant statistical difference between the two groups in the period of treatment with placebo. This early stage trial indicated that the multi-strain Lactobacillus capsule is safe and the results provided some evidence that it accelerated gastric emptying in healthy adults above 40 years of age and may become a therapeutic approach in future trials for pathological gastric emptying delay, by implication, especially in diabetic gastroparesis.
引用
收藏
页码:653 / 660
页数:8
相关论文
共 9 条
  • [1] A Novel Multi-Strain Vaginal Synbiotic Is Effective in Optimizing the Vaginal Microbiome: Results From a Randomized, Placebo-Controlled Clinical Trial
    Ravel, J.
    Simmons, S.
    Jawa, E. Greenwood
    Gottfried, S.
    Greene, M.
    Kellogg-Spadt, S.
    Gevers, D.
    Harper, D.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2024, 231 (06)
  • [2] CLINICAL-EVALUATION OF KINETIC-MODEL FOR THE QUANTIFICATION OF LIVER-FUNCTION WITH TC-99M PMT AND DYNAMIC SCINTIGRAPHY
    TSUDA, T
    MURASE, K
    TANADA, S
    SUGAWARA, Y
    INOUE, T
    FUJII, T
    HAMAMOTO, K
    JOURNAL OF NUCLEAR MEDICINE, 1993, 34 (05) : P167 - P167
  • [3] The effects of the DDS-1 strain of lactobacillus on symptomatic relief for lactose intolerance - a randomized, double-blind, placebo-controlled, crossover clinical trial
    Michael N. Pakdaman
    Jay K. Udani
    Jhanna Pamela Molina
    Michael Shahani
    Nutrition Journal, 15
  • [4] The effects of the DDS-1 strain of lactobacillus on symptomatic relief for lactose intolerance - a randomized, double-blind, placebo-controlled, crossover clinical trial
    Pakdaman, Michael N.
    Udani, Jay K.
    Molina, Jhanna Pamela
    Shahani, Michael
    NUTRITION JOURNAL, 2016, 15
  • [5] A randomized placebo-controlled clinical trial of a multi-strain probiotic formulation (Bio-Kult®) in the management of diarrhea- predominant irritable bowel syndrome
    Ishaque, Shamsuddin M.
    Khosruzzaman, S. M.
    Ahmed, Dewan Saifuddin
    Sah, Mukesh Prasad
    BMC GASTROENTEROLOGY, 2018, 18
  • [6] A randomized placebo-controlled clinical trial of a multi-strain probiotic formulation (Bio-Kult®) in the management of diarrhea-predominant irritable bowel syndrome
    Shamsuddin M. Ishaque
    S. M. Khosruzzaman
    Dewan Saifuddin Ahmed
    Mukesh Prasad Sah
    BMC Gastroenterology, 18
  • [7] Erratum to: the effects of the DDS-1 strain of lactobacillus on symptomatic relief for lactose intolerance - a randomized, double-blind, placebo-controlled, crossover clinical trial
    Michael N. Pakdaman
    Jay K. Udani
    Jhanna Pamela Molina
    Michael Shahani
    Nutrition Journal, 15
  • [8] the effects of the DDS-1 strain of lactobacillus on symptomatic relief for lactose intolerance - a randomized, double-blind, placebo-controlled, crossover clinical trial (vol 15, 56, 2016)
    Pakdaman, Michael N.
    Udani, Jay K.
    Molina, Jhanna Pamela
    Shahani, Michael
    NUTRITION JOURNAL, 2016, 15
  • [9] Effect of a Multi-Strain Probiotic Supplementation to Manage Stress during the COVID-19 Pandemic: A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Clinical Trial
    Nobile, Vincenzo
    Puoci, Francesco
    NEUROPSYCHOBIOLOGY, 2023, 82 (02) : 61 - 71